UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000051785 |
|---|---|
| Receipt number | R000059098 |
| Scientific Title | Approaches to delirium at the end of life in patients with cancer: a scoping review |
| Date of disclosure of the study information | 2023/08/01 |
| Last modified on | 2023/08/31 23:28:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Approaches to delirium at the end of life in patients with cancer: a scoping review
Acronym
Approaches to delirium at the end of life in patients with cancer: a scoping review
Scientific Title
Approaches to delirium at the end of life in patients with cancer: a scoping review
Scientific Title:Acronym
Approaches to delirium at the end of life in patients with cancer: a scoping review
Region
| Japan |
Condition
Condition
Cancer
Classification by specialty
| Hematology and clinical oncology | Psychiatry |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To organize or identify, by reviewing the findings, recommended approaches to delirium at the end of life in patients with cancer.
Basic objectives2
Others
Basic objectives -Others
To map approaches to delirium at the end of life in patients with cancer.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Approaches to delirium at the end of life in patients with cancer.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Patients with cancer (more than or equal to 80%)
2. Interventions for delirium at the end of life
3. Both pharmacologic and non-pharmacologic interventions are included in this study.
The study design to be considered for inclusion is as follows:
1. If there were at least two randomized controlled trial (RCT)s, inclusion was completed.
2. If there were less than 2 RCTs, we included non-RCTs or observational studies with control groups.
3. If there were no RCTs/non-RCTs/observational studies with control groups, single-arm observational studies were considered for inclusion.
Key exclusion criteria
1. Duplicate publications
2. Conference proceedings
3. Research on sedation
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Mari |
| Middle name | |
| Last name | TAKEUCHI |
Organization
Keio University, School of Medicine
Division name
Department of Neuropsychiatry
Zip code
160-8582
Address
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, JAPAN
TEL
03-3353-1211
maritakeuchi@keio.jp
Public contact
Name of contact person
| 1st name | Mari |
| Middle name | |
| Last name | TAKEUCHI |
Organization
Keio University, School of Medicine
Division name
Department of Neuropsychiatry
Zip code
160-8582
Address
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, JAPAN
TEL
03-3353-1211
Homepage URL
maritakeuchi@keio.jp
Sponsor or person
Institute
Keio University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
N/A
N/A
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 07 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data sources and search strategy
We will conduct a scoping review of approaches to delirium at the end of life in patients with cancer. This scoping review will search the following four databases: the Ichushi-Web of the Japan Medical Abstracts Society ver.5, Cochrane Library, EMBASE and MEDLINE, on 0831 2023. The search will include all relevant terms such as "Delirium" and "End of life".
Selection of studies
Two review authors will independently check to ensure that studies meet the inclusion criteria. If the reviewers disagree, the final rating will be determined by consensus. If necessary, another reviewer will be involved.
Management information
Registered date
| 2023 | Year | 08 | Month | 01 | Day |
Last modified on
| 2023 | Year | 08 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059098
